UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000002603
Receipt No. R000003176
Scientific Title Phase I study of Gemtuzumab Ozogamicin given in combination with Enocitabine and Daunorubicin as induction therapy for elderly patients with acute myeloid leukemia
Date of disclosure of the study information 2009/10/13
Last modified on 2011/10/12 11:54:33

No. Disposal Last modified on Item of update
1 Insert 2009/10/08 16:47:33
2 Update 2011/10/12 11:54:33 Recruitment status
Date of closure to data entry


Contact us.